Диссертация (1141097), страница 20
Текст из файла (страница 20)
25. –P. 360-368.203.Plewka, A. Processes of apoptosis and cell proliferation in uterine myomasoriginating from reproductive and perimenopausal women / A. Plewka,D. Plewka, P. Madej, G. Nowaczyk et al. // Folia Histochem Cytobiol. – 2011. –Vol. 49 (3). – P. 398-404.204.Quinn, C. Pinopodes: a questionable role in endometrial receptivity /C. Quinn, R. Casper // Hum. Reprod. Update. – 2009. – Vol.
15. – P. 229-236.205.Rackow, B.W. Submucosal uterine leiomyomas have a global effect onmolecular determinants of endometrial receptivity / B.W. Rackow, H.S. Taylor //Fertility and Sterility. – 2010. – Vol. 93 (6). – P. 2027-2034.206.Rakesh, S. Laparoscopic myomectomy with uterine artery ligation: reviewarticle and comparative analysis / S. Rakesh, S.
Meenakshi, M. Chaitali,R. Shweta et al. // J. Gynecol. Endosc. Surg. – 2011. – Jan-Jun. – Vol. 2 (1). –P. 3-10.207.Ren, Y. Different effects of epidermal growth factor on smooth musclecells derived from human myometrium and from leiomyoma / Y. Ren, H. Yin,R. Tian et al. // Fertility and Sterility. – 2011. – Vol. 96 (4).
– P. 1015-1020.208.Robinson, R.S. Angiogenesis and vascular function in the ovary /R.S. Robinson, K.J. Woad, A.J. Hammond, M. Laird et al. // Reproduction. –2009. – Dec. – Vol. 138 (6). – P. 869-881.122209.Segars, J.H. Proceedings from the third national institutes of healthinternationalcongressonadvancesinuterineleiomyomaresearch:comprehensive review, conference summary and future recommendations /J.H. Segars, E.C. Parrott, J.D.
Nagel, X.C. Guo et al. // Hum. Reprod. Update. –2014. – May-Jun. – Vol. 20 (3). – P. 309-333.210.Sell, S.M. Molecular analysis of chromosome 7q21.3 in uterineleiomyoma: analysis using markers with linkade to insulin resistance / S.M. Sell,O. Altungoz, A.A. Prowse et al. // Cancer Genetics and Cytogenetics. – 1998. –Vol. 100. – № 2. – P. 165–168.211.Shaik, N.A. Detection of somatic mutations and germline polymorphismsin mitochondrial DNA of uterine fibroids patients / N.A.
Shaik, W.G. Lone,I.A. Khan, S. Vaidya et al. // Genet. Test Mol. Biomarkers. – 2011. – Jul-Aug. –Vol. 15 (7-8). – P. 537-541.212.Shen, Q. Effects of mifepristone on uterine leiomyoma in premenopausalwomen: a meta-analysis / Q. Shen, Y. Hua, W. Jiang, W. Zhang et al. // Fertil.Steril. – 2013. – Dec.
– Vol. 100 (6). – P. 1722-1726.213.Shen, Y. Environmental exposure and risk of uterine leiomyoma: anepidemiologic survey / Y. Shen, Q. Xu, J. Xu, M.L. Ren, Y.L. Cai // Eur. Rev.Med. Pharmacol. Sci. – 2013. – Vol. 17 (23). – P. 3249-3256.214.Somigliana, E. Fibroids and female reproduction: a critical analysis of theevidence / E. Somigliana, P. Vercellini, R. Daguati, R. Pasin et al. // Hum.Reprod.
Update. – 2007. – Vol. 13. – Р. 465-476.215.Sprague, B.J. The effects of the ovarian cycle and pregnancy on uterinevascularimpedanceanduterinearterymechanics/B.J. Sprague,T.M. Phernetton, R.R. Magness, N.C. Chesler // Eur. J. Obstet. Gynecol. Reprod.Biol. – 2009. – May.
– Vol. 44 (1). – P. 170-178.216.Eisinger, S.H.Low-dosemifepristoneforuterineleiomyomata/S.H. Eisinger, S. Meldrum, K. Fiscella et al. // Obstetrics & Gynecology. – 2003.– Vol. 101. – P. 243-250.123217.Strowitzki, T. The human endometrium as a fertility-determining factor /T. Strowitzki, A. Germeyer, R. Popovici, M. von Wolff // Hum Reprod Update.
–2006. – Vol. 12 (5). – P. 617-630.218.Sudarshan, S. Mechanisms of disease: hereditary leiomyomatosis and renalcell cancer - a distinct form of hereditary kidney cancer / S. Sudarshan,P.A. Pinto, L. Neckers, W.M. Linehan // Nature Clinical Practice Urology. –2007. – Vol.
4 (2). – P. 104-110.219.Suo, G. Platelet-derived growth factor C is upregulated in human uterinefibroids and regulates uterine smooth muscle cell growth / G. Suo, Y. Jiang,B. Cowan, J.Y.J. Wang // Biology of Reproduction. – 2009. – Vol. 81 (4). –P. 749-758.220.Suzuki, A. Expression of p 53 and p 21 (WAF-1), apoptosis, andproliferation of smooth muscle cells in normal myometrium during the menstrualcycle: implication of DNA damage and repair for leiomyoma development /A. Suzuki, M. Kariya, N. Matsumura, T. Baba et al.
// Med. Mol. Morphol. –2012. – Dec. – Vol. 45 (4). – P. 214-221.221.Taiki, Samejima. Identifying patients who can improve fertility withmyomectomy / Taiki Samejima, Kaori Koga, Hanako Nakae, Osamu WadaHiraike et al. // Eur. J. Obstet. Gynecol. Reprod. Biol. – 2014. – Dec. – Vol. 185.– P.
28-32.222.Takasaki, A. Luteal blood flow and luteal function / A. Takasaki,H. Tamura, K. Taniguchi, H. Asada et al. // J. Ovarian. Res. – 2009. – Jan. –Vol. 14 (2). – P. 1.223.Tal, R. The role of angiogenic factors in fibroid pathogenesis: potentialimplications for future therapy / R. Tal, J.H.
Segars // Hum. Reprod. Update. –2014. - Mar-Apr. – Vol. 20 (2). – P. 194-216.224.Tamura, H. Changes in blood-flow impedance of the human corpus luteumthroughout the luteal phase and during early pregnancy / H. Tamura, A. Takasaki,K. Taniguchi, A. Matsuoka et al. // Fertil. Steril. – 2008. – Dec. – Vol. 90 (6).
–P. 2334-2339.124225.Tawfeek, M. Assessment of leukemia inhibitory factor and glycoprotein130 expression in endometrium and uterine flushing: a possible diagnostic toolfor impaired fertility / M. Tawfeek, M. Eid, A. Hasan, M. Mostafa, H. El-Serogy// BMC Womens Health. – 2012. – Apr. – Vol. 20 (12). – P. 10.226.Torre, A. Uterine artery embolization for severe symptomatic fibroids:effects on fertility and symptoms / A. Torre, B. Paillusson, V. Fain, P. Labauge etal. // Hum.
Reprod. – 2014. – Vol. 29 (3) – P. 490-501.227.Tulandi, T. Ovarian reserve after uterine artery embolization forleiomyomata / T. Tulandi, A. Sammour, D. Valenti, T.J. Child et al. // Fertil.Steril. – 2002. – Vol. 178 (1). – P. 197–198.228.Velez Edwards, D.R. Association of age at menarche with increasingnumber of fibroids in a cohort of women who underwent standardized ultrasoundassessment. / D.R. Velez Edwards, D.D. Baird, K.E. Hartmann // Am.
J.Epidemiol. – 2013. – Aug. – Vol. 1. – Supl. 178 (3). – P. 426-433.229.Walker, C.L. Role of hormonal and reproductive factors in the etiology andtreatment of uterine leiomyoma / C.L. Walker // Recent Progress in HormoneResearch. – 2002. – Vol. 57. – P. 277-294.230.Wallach, E.E. Clinical gynecologic series: an expert’s vies uterinemyomas: an overview of development, clinical features, and management /E.E.
Wallach, N.F. Vlahos // Obstetrics & Gynecology. – 2004. – Vol. 104. –P. 393–406.231.Wallach, E.E. Myomata uteri and infertility / E.E. Wallach, K.K. Vu //Obstet. Gynecol. Clin. North. Am. – 1995. – Dec. – Vol. 22 (4). – P. 791-799.232.Wu, M. The low expression of leukemia inhibitory factor in endometrium:possible relevant to unexplained infertility with multiple implantation failures /M. Wu, Y. Yin, M. Zhao, L. Hu, Q. Chen // Cytokine. – 2013. – May. –Vol.
62 (2). – P. 334-339.233.Xiao, Y. Leukemia inhibitory factor is dysregulated in the endometriumand uterine flushing fluid of patients with adenomyosis during implantation125window / Y. Xiao, X. Sun, X. Yang, J. Zhang et al. // Fertil. Steril. – 2010. – Jun.– Vol. 94 (1). – P. 85-89.234.Yaman, C. Accuracy of three-dimensional transvaginal ultrasound in uterusvolume measurements: comparison with two-dimensional ultrasound / C. Yaman,K. Jesacher, W. Polz // Ultrasound. Med. Biol.
– 2003. –Vol. 29. – P. 1681-1684.235.Yerushalmi, G.M. Vaginal mifepristone for the treatment of symptomaticuterine leiomyomata: an open-label study / G.M. Yerushalmi, Y. Gilboa,A. Jakobson-Setton, Y. Tadir et al. // Fertil. Steril. – 2014. – Feb. – Vol.
101 (2).– P. 496-500.236.Ying, Z. Dual actions of progesterone on uterine leiomyoma correlate withthe ratio of progesterone receptor A / Z. Ying, Z. Weiyuan // B. GynecologicalEndocrinology. – 2009. – Vol. 25 (8). – P. 520-523.237.Yoshino, O. Decreased pregnancy rate is linked to abnormal uterineperistalsis caused by intramural fibroids / O. Yoshino, T. Hayashi // Hum.Reprod. – 2010.
– Vol. 25 (10). – P. 2475-2479.238.Younis, J.S. Prospective evaluation of basal stromal Doppler studies inwomen with good ovarian reserve and infertility undergoing in vitro fertilizationembryo transfer treatment: patients with polycystic ovary syndrome versusovulatory patients / J.S. Younis , J.E. Jadaon , S. Haddad, I. Izhaki, M. Ben-Ami// Fertil.
Steril. – 2011. – Apr. – Vol. 95 (5). – P. 1754-1758..